
.@aditxt $ADTX Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025
#StocksToWatch #stocksinnews #investors #smallcaps
businesswire.com/news/home/2025…

English












